Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

A 2026 target trial emulation has found that glucagon-like peptide, also known as GLP-1, which is used by type-2 diabetes patients, can raise the risk of suffering from erectile dysfunction. According to a report published in the European Medical Journal, the impact of GLP-1s on sexual health outcomes in diabetic men has been inconsistent and limited. Erectile dysfunction, however, has been a prominent complication affecting 50 per cent of men with type-2 diabetes over their lifetime.

The effect of GLP-1 on men with type-2 diabetes

For this, researchers analysed the electronic health records of men aged 18 years and above with type-2 diabetes in the US from January 2019 to September 2024. Participants were started on treatment with either dipeptidyl peptidase-4 inhibitors (DPP4i) or GLP-1, with 5,524 and 4,910 individuals, respectively. Men with a history of erectile dysfunction diagnosis or end-stage renal disease were not part of the study population. The mean age of these men was 63 years, and the average BMI was 32.8—55 per cent of participants were White, and 23 per cent were Black. GLP-1 users were younger and had a higher prevalence of obesity compared to DPP4i users.

Higher rate of erectile dysfunction

Experts involved in the study found that the incidence of erectile dysfunction in the GLP-1 group was about 35 cases per 1,000 person-years. In the case of DPP4i users, the number dropped to 28 per 1,000 person-years. Hence, people in the GLP-1 cohort had a 26 per cent higher risk of developing erectile dysfunction over a three-year follow-up period. Results were consistent across subgroups; however, they lacked statistical significance after adjustment for negative outcomes.

Can GLP-1 cause erectile dysfunction?

Researchers noted that the findings of the target trial emulation suggest that sexual health outcomes must be considered in diabetic men, especially those dealing with type-2 diabetes and undergoing treatment with GLP-1 drugs. These findings also highlight the need for randomised trials with standardised erectile dysfunction assessments to further investigate biological pathways.

What complications does type-2 diabetes cause in men?

Type-2 diabetes can cause the following complications in men:

1. Heart disease
2. Stroke
3. Erectile dysfunction
4. Kidney disease
5. Retrograde ejaculation
6. Lower testosterone levels
7. Urinary retention or frequent urination
8. Vision loss—diabetic retinopathy

New global guidelines have just been released for breast cancer screening, and they involve the introduction of artificial intelligence in the process. Breast cancer is one of the most commonly diagnosed forms of tumour in women globally. In India, it is the most common form of cancer detected in women living in metro cities. According to the National Comprehensive Cancer Network (NCCN), a non-profit alliance of 33 cancer treatment centres in the US, women aged 35 years and above should be eligible for AI-powered mammogram risk assessment rather than at a later stage.

Why is timely prediction of cancer risk important?

The NCCN aims to boost the diagnosis rates of breast cancer by paving the way for accurate predictions of risks. This will, over time, help achieve timely screening. As per experts, this change in global breast cancer screening guidelines, especially the integration of AI in the process, marks a paradigm shift—from a detection-first to a prediction-first approach. Historically, mammograms were used after the age of 40 for the detection of existing cancers. The modern guidelines, however, recommend that women get screened from the age of 35 onwards, with AI algorithms used to predict future risks.

What this means for India

Experts say that this shift is important for India. In India, breast cancer is the most prevalent form of tumour among women, and delayed diagnosis is one of the reasons responsible for the current mortality rate. Breast cancer is also often diagnosed late because of the unavailability and limited accessibility of screening facilities. Introducing AI in this process can help bridge the gap in several ways.

Doctors say that the introduction of AI in the breast cancer screening process will help facilitate the identification of high-risk patients, regardless of their family history or the presence of genetic markers. This is important because most cases of breast cancer do not arise from these factors. This helps provide screening in a way that does not require universal testing.

Traditional screening methods for breast cancer

Traditionally, cancer screening largely depends on family history and age. AI, however, can now analyse large volumes of imaging data, clinical history, breast density, and genetic factors for a more personalised approach and targeted diagnostic methods. The adoption of AI-driven risk assessment can help improve patient outcomes, as per doctors.

Use of AI in breast cancer detection

Women at high risk of breast cancer can make detection easier for themselves by making use of advanced modalities such as MRI. An MIT-developed AI-based breast cancer risk model can detect tumours up to five years in advance using mammographic data alone. This AI-based risk assessment technique has also been recommended by global experts and is published in The Lancet. The study found consistent favourable outcomes.

Rising global temperatures are driving heatwave conditions in India, said the Indian government, while releasing an advisory to warn people about the increased health risks.

Taking to the social media platform X, the Ministry of Health and Family Welfare urged the public to take precautions during extreme heat.

"Heat waves are increasing due to rising global temperatures," said the Ministry in the advisory.

It shared safety measures and an informative poster explaining the impact of rising temperatures and steps to manage heat stroke.

The poster highlighted that a rise of 1 degree Celsius in global temperatures can lead to longer durations of heatwaves.

Further, it stated that insufficient hydration during heatwaves reduces the body's natural ability to cool itself, which can result in heat stroke.

The poster also detailed preventive measures to avoid heat stroke. It also advised people to avoid heavy work during mid-noon hours, drink plenty of water, avoid consuming heavily caffeinated or sugary drinks as they may cause dehydration, wear light-colored clothes, and take frequent breaks while working outdoors.

Which States Are At Risk?

The India Meteorological Department (IMD) has warned of heatwave conditions in several parts of the country.

Regions likely to face extreme heatwave conditions until April 20 include Telangana and Rayalaseema, Madhya Maharashtra and Marathwada, North Interior Karnataka, Madhya Pradesh, Chhattisgarh, Vidarbha, Odisha, Jharkhand, and West Rajasthan.

In addition, hot and humid weather conditions are expected in coastal regions such as Kerala, Tamil Nadu, Gujarat, and Coastal Andhra Pradesh.

Meanwhile, the national capital saw its hottest day of the year on Wednesday, as temperatures climbed sharply, signaling the onset of harsher summer conditions. According to IMD, the maximum temperature at Safdarjung, the city’s base station, touched 39.2 degrees Celsius, about 3 degrees above normal. This surpassed Tuesday’s 38.2 degrees Celsius, marking a noticeable upward trend.

While the mercury is expected to inch closer to 42 degrees Celsius by Friday, the weather office has ruled out heatwave conditions for at least the next week.

“A gradual rise is expected in maximum temperatures by 2-3 degrees during the next three days and fall by 1-2 degrees thereafter. The maximum temperatures are likely to be above normal to appreciably above normal during the next seven days," Times Of India quoted a Met official as saying.

As per the weather department, despite a slight chance of light rain in parts of Haryana and NCR on April 17 and 18, there is no relief expected for Delhi.

Forecasts suggest daytime temperatures will hover between 39 degrees Celsius and 41 degrees Celsius on Thursday, rising further to 40-42 degrees Celsius from Friday through Sunday.

The IMD has cautioned that such above-normal temperatures could pose moderate health risks, especially for infants, elderly individuals, and those with chronic illnesses.

Hydration Is key, Say Doctors

Dr. Anil Gomber, Director and Senior Consultant – Internal Medicine & Diabetologist, Yatharth Hospital, told HealthandMe: “It is crucial to take preventive measures to avoid heat-related illnesses".

Prolonged exposure to high temperatures can lead to dehydration, heat exhaustion, and heatstroke, which can be fatal if untreated.

Heat also places extra strain on the heart and lungs, increasing the risk of heart attacks and respiratory distress.

Heatwaves can increase the risk of deaths among the elderly and those with underlying medical conditions. It can also affect healthy and young people. Exposure to intense heat can cause headaches, dizziness, cramps, and fainting, particularly for those working outdoors or engaging in strenuous activity.

"Elderly people, kids, and those with chronic conditions like heart disease or diabetes face higher risks, so check on neighbors and family daily," Dr. Meenakshi Jain Principal Director & HOD Internal Medicine, Max Super Speciality Hospital, told HealthandMe.

She urged people to "watch for warning signs like dizziness, rapid heartbeat, nausea, or confusion, and move to a cool area immediately if they appear—seek medical help for severe symptoms. Keep homes cooler by closing curtains during the day and opening windows at night".

How To Stay Safe

• Stay well-hydrated by drinking plenty of water
• Avoid caffeine
• Avoid stepping out during peak afternoon hours
• Wear light, loose, and breathable clothing,
• Use protective gear like caps or umbrellas when outdoors
• Avoid excessive physical activity in the sun.
• Never leave children or elderly individuals in parked vehicles. Include fruits and fluids in your diet to maintain electrolyte balance.
• If you experience dizziness, headache, or fatigue, seek medical attention promptly, as early care can prevent serious complications.